Founded in 2015 by Rajneesh and Anita Bhandari, FutureCure Health develops and operates NeuroEquilibrium, an integrated platform that combines proprietary diagnostic hardware, cloud-based remote software and treatment protocols to manage vertigo and dizziness. The company partners with hospitals, ENT clinics and neurology centres to provide non-invasive vestibular diagnostics and targeted therapy. It currently runs more than 300 clinics across India and 16 other countries, having treated over 150,000 patients. FutureCure plans to scale its vertigo offering globally while expanding into other chronic lifestyle conditions such as migraine and diabetes. The firm positions its deep-tech tools as a means to bridge the shortage of specialist doctors worldwide. Recent funding underscores management’s view that globally relevant healthcare technology can be built in India. The business generates revenue from its clinical network and technology deployments, though specific financial figures beyond patient and clinic counts were not disclosed.

Total raised

$16M

Funding rounds

2

Latest round

Series B

Latest activity

Jan 2026